Business Insider5d
Viking Therapeutics initiated with a Neutral at Citi
Citi analyst David Lebowitz initiated coverage of Viking Therapeutics (VKTX) with a Neutral rating and $38 price target Viking’s VK2735 is an “intriguing potential blockbuster,” with its GLP ...
Business Insider5d
Viking Therapeutics price target lowered to $96 from $109 at B. Riley
B. Riley lowered the firm’s price target on Viking Therapeutics (VKTX) to $96 from $109 and keeps a Buy rating on the shares. The firm remains a buyer on share weakness following the Q4 report.
The New York Times6d
Movie Reviews
In this documentary, the artist depicts what a more just and beautiful world might look like. By Alissa Wilkinson Ke Huy Quan and Ariana DeBose play reunited former associates from a criminal ...
San Diego Union-Tribune3d
San Diego Union-Tribune
🚙 Waymo test-driving in San Diego ⛳ Genesis Invitational 🚗 No free parking on Sundays? 🏨 Hotel del Coronado $160M renovation 🎇 Big Bay Boom update ...